The Cross-Section of Law, Technology, and Innovation
Law students, practicing attorneys, and industry professionals in today’s business environment regularly encounter complex legal issues as practitioners and policy makers at the cross-section of law, technology, and innovation. Recognizing and effectively addressing these issues are increasingly paramount to their success and the delivery of the best possible work product and client service. That is one of the reasons that Gibbons endowed $1 million to the Seton Hall University School of Law to establish the Gibbons Institute of Law, Science & Technology
. This gift, which is among the largest donations to a law school by a New Jersey law firm, provides funding to assist the law school in educating and training the next generation of attorneys and other professionals in the technology and scientific communities to address the complex issues they face in the 21st century. The Institute also draws on the experience and knowledge of Gibbons attorneys, as well as leading experts in the area, to provide resources and support to the technology and scientific communities through publications, symposia, and events.
A Forum on Law and Technology Issues
The Gibbons Institute is a forum for lawyers, judges, scientists, and government officials to discuss the legal, political, and social problems that will continue to arise as scientific and technological changes challenge existing laws and legal institutions. With the Gibbons Institute, Seton Hall Law School has the capability to train professionals in health and intellectual property law and advance its J.D. and M.S.J. degrees to better meet the needs of industries facing cutting-edge technological and associated legal challenges. The Institute also allows the university to introduce an LL.M. degree in intellectual property law; to support special events, lectures, and communications efforts; and establish itself as a premier school in the field of Intellectual Property. With New Jersey as a hub of IP law – given the number of technology companies headquartered in the state, outstanding engineering and medical schools, proximity to New York, and sophisticated bench at both the district court and state levels – the Gibbons Institute can serve as a center for excellence to education, train, and engage students and practitioners alike on the range of related issues.
Several prominent pharmaceutical companies, including Schering-Plough Corporation, sanofi-aventis, Johnson & Johnson, and Bristol-Myers Squibb, designated an additional $8.1 million in corporate gifts for the establishment of The Center for Health & Pharmaceutical Law at Seton Hall Law School.